海特生物股价下跌4.17% 公司药品生产许可证完成变更

Group 1 - The stock price of Hite Bio on August 21 closed at 50.73 yuan, a decrease of 4.17% compared to the previous trading day [1] - The trading volume on that day was 78,045 hands, with a transaction amount of 404 million yuan [1] - Hite Bio operates in the biopharmaceutical industry, focusing on the research, production, and sales of biological products and innovative drugs [1] Group 2 - On August 21, the company announced it had obtained a new "Drug Production License" from the Hubei Provincial Drug Administration, with the main change being the reduction of the entrusted production relationship with Hubei Sihuan Pharmaceutical Co., Ltd [1] - The company stated that this change would not have a significant impact on its performance [1] - As of August 20, the number of shareholders was 13,430, a decrease of 1,003 from August 10 [1] Group 3 - In terms of capital flow, on August 21, the net outflow of main funds was 70.27 million yuan, with a cumulative net outflow of 108 million yuan over the past five days [1]